![News - CHMP Recommends Authorisation of Comirnaty Variant (BioNTech/Pfizer) Adapted to Omicron BA.4/BA.5 As Booster Vaccination for Children Aged 5 to 11 Years - Paul-Ehrlich-Institut News - CHMP Recommends Authorisation of Comirnaty Variant (BioNTech/Pfizer) Adapted to Omicron BA.4/BA.5 As Booster Vaccination for Children Aged 5 to 11 Years - Paul-Ehrlich-Institut](https://www.pei.de/SharedDocs/Bilder/EN/newsroom-en/hp-news-pm/comirnaty-booster-opinion-adolescents.jpg?__blob=thumbnail&v=4)
News - CHMP Recommends Authorisation of Comirnaty Variant (BioNTech/Pfizer) Adapted to Omicron BA.4/BA.5 As Booster Vaccination for Children Aged 5 to 11 Years - Paul-Ehrlich-Institut
![Vaccino anti-Covid, richiamo con bivalente per i fragili dai 5 agli 11 anni - Salute, sport e buona vita - Regione Puglia Vaccino anti-Covid, richiamo con bivalente per i fragili dai 5 agli 11 anni - Salute, sport e buona vita - Regione Puglia](https://www.regione.puglia.it/documents/56205/4225137/dosi+vaccino.jpg/b40cd015-007e-d2e6-9519-2ddd13eeed1a?t=1673955186191)
Vaccino anti-Covid, richiamo con bivalente per i fragili dai 5 agli 11 anni - Salute, sport e buona vita - Regione Puglia
Pfizer Canada - Another step forward in the fight against COVID-19: Health Canada has authorized COMIRNATY Original & Omicron BA.4/BA.5 (Pfizer-BioNTech bivalent, Omicron BA.4/BA.5-adapted COVID-19 vaccine) as a booster dose for Canadians
![Comirnaty (COVID-19 Vaccine, mRNA) and Comirnaty Original & Omicron BA.4/ BA.5 [bivalent] | Pfizer Medical Information - Canada Comirnaty (COVID-19 Vaccine, mRNA) and Comirnaty Original & Omicron BA.4/ BA.5 [bivalent] | Pfizer Medical Information - Canada](https://www.pfizermedicalinformation.ca/images/custom/pmi-sticky-search-logo.png)
Comirnaty (COVID-19 Vaccine, mRNA) and Comirnaty Original & Omicron BA.4/ BA.5 [bivalent] | Pfizer Medical Information - Canada
![News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut](https://www.pei.de/SharedDocs/Bilder/EN/newsroom-en/hp-news-pm/omicron-ba5-chmp.jpg?__blob=thumbnail&v=6)
News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut
![Are you staying up to date on your COVID-19 vaccinations?' asks Peterborough's medical officer of health | kawarthaNOW Are you staying up to date on your COVID-19 vaccinations?' asks Peterborough's medical officer of health | kawarthaNOW](https://kawarthanow.com/wp-content/uploads/2022/10/pfizer-bivalent-vaccine.jpg)